Contact Info
  • 425 University Ave
  • Suite 601
  • Toronto, ONT M5G1T6
  • Canada
Business Description

Drug / OTC Research and Development

Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Jan 29, 2009
Audited Financials Unaudited
Latest Report Mar 31, 2014 Quarterly Report
CIK 0001071272
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC – Industry Classification 2834 – Pharmaceutical preparations
Business Status Development Stage Company a/o May 05, 1998
Incorporated In: WY, USA
Year of Inc. 1998
Employees 4 a/o Nov 27, 2012
Company Officers/Contacts
John Adams CFO
Carla Pepe Secretary, CEO
Company Directors
John Adams
Company Notes
  • Formerly=LAM Industries Inc. until 3-2010
  • Formerly=L.A.M. Pharmaceutical Corp. until 4-2009
Service Providers

Accounting/Auditing Firm

KBL, LLP
114 West 47th Street, 19th Floor
Suite 1900
New York, NY, 10036
United States
EAPH Security Details
Share Structure
Market Value1 $7,270,805 a/o Aug 14, 2014
Shares Outstanding 498,000,370 a/o Apr 01, 2014
Float 473,245,458 a/o Apr 01, 2014
Authorized Shares 500,000,000 a/o Apr 01, 2014
Par Value 0.0001
Shareholders
Shareholders of Record 198 a/o Apr 01, 2014
Security Notes
  • Capital Change=shs decreased by 1 for 3000 split. Pay date=04/30/2009.
Short Selling Data
Short Interest 0 (-100%)
Jul 31, 2014
Significant Failures to Deliver No
Transfer Agent(s)
Corporate Stock Transfer, Inc.